Pre-Clinical Models of Infectious Diseases

Active Master IDIQ Awarded

Federal agency
Awardees
40
Task orders
28
Obligated
$19,640,507

Vehicle facts

Opportunity
Agency
Combined task order value
  • $19,640,507 Current, with exercised options
  • $57,429,589 Potential, with all options
Last date to order 32% complete
Shared ceiling 13% used
$146,300,000.00

IDV award and task order details come from SAM.gov/FPDS.

About this vehicle

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Master IDIQ on July 15, 2024, for pre-clinical models of infectious diseases with a shared ceiling of $146.3 million and ordering authority extending through July 14, 2031. Ordering remains open with approximately four years and eleven months of procurement window remaining.

The IDIQ funds development and deployment of animal and in vitro replacement models for screening, evaluating, and supporting clinical evaluation of countermeasures against infectious agents. Task orders span murine models for seasonal and avian influenza, Lassa virus, cytomegalovirus, herpes simplex viruses, and antibiotic-resistant urinary tract infections; hamster and guinea pig models; human lung microphysiological systems; skin xenografts; rabbit models for papillomaviruses; and repository and reagent distribution services. Pricing structures vary across Cost No Fee, Cost Plus Fixed Fee, and Firm Fixed Price arrangements, with individual order ceilings ranging from approximately $163,000 to $4.8 million.

Eighteen task orders have been awarded totaling $29.4 million in combined potential value, with $9.9 million (34%) obligated. Ordering pace has slowed from eight orders in 2024 and six in 2025 to four through mid-2026. All task orders serve NIAID exclusively; no other federal agencies are represented in the portfolio. Competition is distributed across 13 distinct prime contractors, predominantly academic and research institutions. University of Texas Medical Branch at Galveston leads by both order count (three orders, $9 million combined potential) and maintains the largest share of vehicle value. Battelle Memorial Institute ($4.8 million), American Type Culture Collection ($4.3 million), University of Georgia Research Foundation ($2.1 million), and Pharmacology Discovery Services Taiwan ($1.9 million) follow. The top five primes by potential value account for 75% of combined task-order value; the broader field includes Utah State University, Colorado State University, and The Research Foundation for State University of New York. All 18 orders are unrestricted and carry no set-aside designation. Task orders typically run 12 to 30 months, with several data-collection and archival orders extending through the vehicle's final ordering date in 2031.

IDV awards

Awardee IDV award Awarded
Bioqual, Inc. 75N93024D00007
The Charles Stark Draper Laboratory, Inc. 75N93024D00008
Mimetas US Inc. 75N93024D00016
Southern Research Institute 75N93024D00021
Texas Biomedical Research Institute 75N93024D00022
University Of South Alabama 75N93024D00041
The University Of Chicago 75N93024D00026
The Regents Of The University Of California. San Francisco 75N93024D00018
The Administrators Of Tulane Educational Fund 75N93024D00031
UK Health Security Agency 75N93024D00032
University Of Florida 75N93024D00034
American Foundation For Biological Research 75N93024D00006
Mriglobal 75N93024D00015
The Johns Hopkins University 75N93024D00014
University Of Tennessee 75N93024D00028
Jackson Laboratory 75N93024D00023
University Of Louisville 75N93024D00036
Sigmovir Biosystems, Inc. 75N93024D00020
The Research Foundation For The State University Of New York 75N93024D00025
The University Of Texas Health Science Center At San Antonio 75N93024D00029
University Of Georgia Research Foundation, Inc. 75N93024D00035
University Of Pittsburgh - Of The Commonwealth System Of Higher Education 75N93024D00039
Colorado State University 75N93024D00009
Ministry Of Defence 75N93024D00010
Saint Louis University 75N93024D00019
University Of Saskatchewan 75N93024D00040
Utah State University 75N93024D00043
Pennsylvania State University 75N93024D00024
University Of North Carolina At Chapel Hill 75N93024D00027
The University Of North Texas Health Science Center At Fort Worth 75N93024D00037
University Of Texas Medical Branch At Galveston 75N93024D00042
IIT Research Institute 75N93024D00012
Institute For Clinical Pharmacodynamics, Inc. 75N93024D00013
Pharmacology Discovery Services Taiwan, LTD. 75N93024D00017
Battelle Memorial Institute 75N93024D00005
Emory University 75N93024D00011
Trustees Of Tufts College 75N93024D00030
American Type Culture Collection 75N93024D00004
Cincinnati Univ Of 75N93024D00033
The Trustees Of The University Of Pennsylvania 75N93024D00038
Show all 40

Latest task orders

Task order Awardee Awarding agency Obligated Last action
Therapeutic testing in murine models of bacterial infection 75N93026F00003 Pharmacology Discovery Services Taiwan, LTD. NIAID $545,542
Task A20 - interventional agent testing against high containment viruses 75N93026F00001 Utah State University NIAID $1,235,656
C02 - PK-PD analysis of mouse model efficacy and PK data for antibacterial… 75N93026F00001 Institute For Clinical Pharmacodynamics, Inc. NIAID $111,080
Pre-clinical models of infectious diseases 75N93026F00002 Utah State University NIAID $250,324
Pre-clinical models of infectious diseases (pcmid) 75N93026F00002 Colorado State University NIAID $748,244
Evaluation of therapeutics and vaccines in mouse models of dengue virus. 75N93026F00001 University Of Texas Medical Branch At Galveston NIAID $844,795
Mouse and guinea PIG models for cytomegalovirus and herpes simplex viruses 75N93025F00001 University Of Texas Medical Branch At Galveston NIAID $2,343,311
Task A10 - test candidate therapeutics against papillomaviruses in mouse and… 75N93025F00001 Pennsylvania State University NIAID $311,680
Task A28 - syrian golden hamster model for testing medical countermeasures… 75N93026F00003 University Of Texas Medical Branch At Galveston NIAID $1,330,980
75N93025F00002 University Of Georgia Research Foundation, Inc. NIAID $1,392,486
Pre-clinical models of infectious diseases 75N93024F00003 Utah State University NIAID $496,800
Pre-clinical models of infectious diseases IDIQ 75N93026F00001 University Of North Carolina At Chapel Hill NIAID $194,646
Pcmid task order B03 - evaluation of antiviral drug candidates against mpox… 75N93025F00001 Battelle Memorial Institute NIAID $1,250,576
Task A02 - university of texas medical branch (utmb) 75N93024F00006 University Of Texas Medical Branch At Galveston NIAID $2,603,774
Therapeutic testing in murine models of fungal infections 75N93026F00001 The University Of Texas Health Science Center At San Antonio NIAID $386,096
Mouse model of neisseria gonorrhoeae infection 75N93026F00002 Pharmacology Discovery Services Taiwan, LTD. NIAID $621,336
Screening candidate countermeasures for viral encephalitis in human central… 75N93026F00002 American Type Culture Collection NIAID $649,709
Screening candidate countermeasures for viral hemorrhagic fever using… 75N93026F00002 University Of Texas Medical Branch At Galveston NIAID $1,388,934
Pcmid C03 - screening candidate countermeasures for seasonal and high path… 75N93026F00001 American Type Culture Collection NIAID $855,413
EO 14398 - pcmid A17 - model development and in vivo screening of antivirals… 75N93026F00001 Colorado State University NIAID $197,555
A12 - murine models of UTI infection caused by antibiotic-resistant bacteria 75N93026F00001 Pharmacology Discovery Services Taiwan, LTD. NIAID $169,160
Base award for task D02 black fly repository support 75N93025F00001 University Of Georgia Research Foundation, Inc. NIAID $355,255
This task order is to conduct the testing of candidate antiviral therapies… 75N93026F00001 The Research Foundation For The State University Of New York NIAID $480,856
Pre-clinical models of infectious diseases 75N93024F00002 Saint Louis University NIAID $400,773
The contractor shall extract historical raw data from all studies performed… 75N93024F00005 University Of Texas Medical Branch At Galveston NIAID $174,528
Show 15 more

Latest 25 of 28 listed here. See the rest on GovTribe.

Top awardees by obligations

Top funding agencies by obligations

Rank Funding agency Obligated Share
1 Department of Health and Human Services $19,640,507 100%

Obligations by fiscal year

Fiscal year Obligated
FY2026 $12,811,432
FY2025 $4,445,079
FY2024 $2,383,996

Quick answers

What is the Pre-Clinical Models of Infectious Diseases contract vehicle?

Pre-Clinical Models of Infectious Diseases is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by National Institute of Allergy and Infectious Diseases (National Institutes of Health), awarded on July 15, 2024.

Which companies hold Pre-Clinical Models of Infectious Diseases?

40 companies hold Pre-Clinical Models of Infectious Diseases's IDV awards, one each. The latest went to Bioqual, Inc. on July 15, 2024. The awardees whose task orders obligated the most are University Of Texas Medical Branch At Galveston, Utah State University and University Of Georgia Research Foundation, Inc.

How much has been spent through Pre-Clinical Models of Infectious Diseases?

28 task orders have been placed under Pre-Clinical Models of Infectious Diseases, obligating $19,640,507.

What is the shared ceiling of Pre-Clinical Models of Infectious Diseases?

Pre-Clinical Models of Infectious Diseases's shared ceiling is $146,300,000; its task orders have used 13% of it.

Which agencies use Pre-Clinical Models of Infectious Diseases the most?

The departments whose task orders under Pre-Clinical Models of Infectious Diseases obligated the most are Department of Health and Human Services ($19,640,507).

How much was obligated through Pre-Clinical Models of Infectious Diseases in fiscal year 2025?

Task orders under Pre-Clinical Models of Infectious Diseases obligated $4,445,079 in fiscal year 2025.

On GovTribe

See this vehicle's full record

  • Every IDV award and task order
  • Funding by agency, awardee, NAICS and set-aside
  • Teaming partners on this vehicle
  • Ask GovTribe AI about this vehicle